People
-
AZTherapies has announced that former Dooner Laboratories and Muro Pharmaceuticals CEO George D. Behrakis has joined the company’s board of directors. Behrakis sold Dooner Laboratories, which manufactured theophylline products for asthma, to Rorer in 1977… Read more . . .
-
AZTherapies, which is developing an inhaled cromolyn sodium/ibuprofen formulation, has named Jay Mohr as Chief Operating Officer, Chief Business Officer, and Head of Commercial Development. Mohr was most recently co-founder and Managing Director of Locust… Read more . . .
-
Members of the OINDP community are remembering inhalation expert Ola Nerbrink, who passed away on June 1, 2019. He was the CEO of Respiron Consulting, which he founded in 2009, and VP of Business Development… Read more . . .
-
Proveris Scientific announced that Stephen McDonald has joined the company’s European team, which is based in the UK. McDonald, who has previously worked with Proveris to provide customer support as an independent contractor, will work… Read more . . .
-
Theravance Biopharma has named former Acorda Therapeutics Chief Business Officer Andrew Hindman as Senior VP and Chief Financial Officer. Hindman, who led Acorda’s acquisition of Inbrija inhaled L-dopa developer Civitas Therapeutics in 2014, also previously served as President… Read more . . .
-
DPI developer TFF Pharmaceuticals said that is has raised $8.17 million through a Series A preferred stock offering and that it will use the funds for R&D. In April 2018, the company announced that it… Read more . . .
-
Nanonization company Nanoform has named former Hovione Senior Project Manager Miguel Cansado as Director of Project Management. Cansado is the third former Hovione employee to join Nanoform this year, following the appointments of Miguel Calado… Read more . . .
-
Robert Clarke is stepping down as CEO of DPI developer Pulmatrix and will be succeeded immediately by current Chief Business Officer Ted Raad, the company said. Clarke, who was appointed CEO in 2012, will stay… Read more . . .
-
Nanoform has announced the appointment of former GSK Particle Size Reduction Lead David Rowe as Head of Manufacturing. In December 2018, the Finnish nanotechnology company announced the construction of a new GMP manufacturing facility in… Read more . . .
-
Neurelis, which submitted an NDA for its Valtoco diazepam nasal spray in September 2018, has announced the appointments of a number of senior management personnel in anticipation of a launch. The appointments announced took place… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 21-October 22: MVIC Symposium, Lund, Sweden
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland